Fidelity Investments
ETTX

Fidelity Investments’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Fidelity Investments’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-400
Closed -$1.08K – 5183
2021
Q3 		$1K Buy
400
+399
+39,900% +$1.08K ﹤0.01% 4249
2021
Q2 		$0 Buy
+1
New +$2 ﹤0.01% 5135

Other funds holding ETTX

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Fidelity Investments's ETTX Position: Q4 2021 in Review

Fidelity Investments sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q4 2021, closing a stake of 400 shares — an estimated $1.08K sold.

Fidelity Investments first reported a position in ETTX in Q2 2021 and held it in 2 quarters. The position peaked at $1K in Q3 2021. 28 funds tracked by Wall St. Rank hold ETTX as of Q4 2021.

  • Fidelity Investments reported no remaining Entasis Therapeutics Holdings Inc. position as of Q4 2021 after selling out during the quarter.
  • Fidelity Investments sold 400 Entasis Therapeutics Holdings Inc. shares in Q4 2021, an estimated $1.08K.
  • Fidelity Investments first reported a position in Entasis Therapeutics Holdings Inc. in Q2 2021 and held it in 2 quarters.
  • Fidelity Investments's Entasis Therapeutics Holdings Inc. position peaked at $1K in Q3 2021.
  • 28 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q4 2021.

Based on Fidelity Investments's 13F filing for Q4 2021, filed 14 Feb 2022.